PH31429A - Substituted 1,2,3,4-tetrahydrocyclopent ÄbÜ indoles, 1,2,3,3a,4,8,a hexahydrocyclopent ÄbÜ indoles and related compounds. - Google Patents

Substituted 1,2,3,4-tetrahydrocyclopent ÄbÜ indoles, 1,2,3,3a,4,8,a hexahydrocyclopent ÄbÜ indoles and related compounds.

Info

Publication number
PH31429A
PH31429A PH43793A PH43793A PH31429A PH 31429 A PH31429 A PH 31429A PH 43793 A PH43793 A PH 43793A PH 43793 A PH43793 A PH 43793A PH 31429 A PH31429 A PH 31429A
Authority
PH
Philippines
Prior art keywords
äbü
indoles
hexahydrocyclopent
tetrahydrocyclopent
substituted
Prior art date
Application number
PH43793A
Other languages
English (en)
Inventor
Helen T Ong
Mark G Palermo
Gerard J O'malley
Michael C Merriman
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of PH31429A publication Critical patent/PH31429A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH43793A 1991-01-18 1992-11-20 Substituted 1,2,3,4-tetrahydrocyclopent ÄbÜ indoles, 1,2,3,3a,4,8,a hexahydrocyclopent ÄbÜ indoles and related compounds. PH31429A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/642,952 US5100891A (en) 1991-01-18 1991-01-18 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds

Publications (1)

Publication Number Publication Date
PH31429A true PH31429A (en) 1998-11-03

Family

ID=24578739

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43793A PH31429A (en) 1991-01-18 1992-11-20 Substituted 1,2,3,4-tetrahydrocyclopent ÄbÜ indoles, 1,2,3,3a,4,8,a hexahydrocyclopent ÄbÜ indoles and related compounds.

Country Status (26)

Country Link
US (1) US5100891A (show.php)
EP (1) EP0496314B1 (show.php)
JP (1) JP2665422B2 (show.php)
KR (1) KR100230881B1 (show.php)
AT (1) ATE158790T1 (show.php)
AU (1) AU650315B2 (show.php)
BR (1) BR9200171A (show.php)
CA (1) CA2059610C (show.php)
CZ (1) CZ282732B6 (show.php)
DE (1) DE69222444T2 (show.php)
DK (1) DK0496314T3 (show.php)
ES (1) ES2109953T3 (show.php)
FI (2) FI102174B (show.php)
GR (1) GR3025318T3 (show.php)
HU (1) HUT67027A (show.php)
IE (1) IE920149A1 (show.php)
IL (1) IL100693A0 (show.php)
MX (1) MX9200206A (show.php)
NO (1) NO178397C (show.php)
NZ (1) NZ241305A (show.php)
PH (1) PH31429A (show.php)
PL (2) PL167465B1 (show.php)
RO (1) RO112505B1 (show.php)
RU (1) RU2077530C1 (show.php)
TW (1) TW198024B (show.php)
ZA (1) ZA92341B (show.php)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298626A (en) * 1991-01-18 1994-03-29 Hoechst-Roussel Pharmaceuticals Incorporated Select cyclopent[b]indoles
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds
AU735249B2 (en) * 1997-07-03 2001-07-05 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds having saturated rings and medicinal compositions containing the same
TWI220143B (en) * 1998-05-13 2004-08-11 Solvay Pharm Gmbh Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds and novel cyclic compounds, and intermediate products
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
UA70334C2 (en) * 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
ATE269337T1 (de) * 1998-10-06 2004-07-15 Janssen Pharmaceutica Nv Trizyclische delta3-pyridine als arzneimittel
IT1317926B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Derivati triciclici dell'indolo ad attivita' antiangiogenica.
EP1654228B1 (en) 2003-06-10 2008-10-22 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
ES2327416T3 (es) 2003-06-12 2009-10-29 Smithkline Beecham Corporation Derivados de tetraidrocarbazol y su uso farmaceutico.
EP1817025A2 (en) * 2004-11-23 2007-08-15 PTC Therapeutics, Inc. Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue
WO2013139929A1 (en) * 2012-03-22 2013-09-26 Ludwig-Maximilians-Universität München Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
KR20140013471A (ko) 2012-07-24 2014-02-05 주식회사 쎄코 진공증착용 발열조립체 및 이를 구비하는 진공증착장치
US10882821B1 (en) 2017-09-26 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514462A (en) * 1966-10-21 1970-05-26 Upjohn Co 1 and 2 ethoxy 3,4,5,10 - tetrahydroazepino(3,4-b) and (2,3-b)indoles and corresponding amino derivatives thereof
US3595874A (en) * 1969-02-28 1971-07-27 Upjohn Co 3,4,5,10-tetrahydroazepino(2,3-b)indol-5a (2h)-ols
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
SU482086A1 (ru) * 1973-11-30 1976-03-15 Всесоюзный Научно-Исследовательски% Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных 1- -амино1,2,3,4-тетрагидрокарбазола
JPS5111760A (show.php) * 1974-06-18 1976-01-30 Ayerst Mckenna & Harrison
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles

Also Published As

Publication number Publication date
FI20001775L (fi) 2000-08-10
KR100230881B1 (ko) 1999-11-15
MX9200206A (es) 1992-08-01
DK0496314T3 (da) 1998-05-18
KR920014777A (ko) 1992-08-25
FI920192L (fi) 1992-07-19
AU650315B2 (en) 1994-06-16
RU2077530C1 (ru) 1997-04-20
JPH04334367A (ja) 1992-11-20
DE69222444T2 (de) 1998-06-04
CZ282732B6 (cs) 1997-09-17
FI102174B1 (fi) 1998-10-30
AU1027992A (en) 1992-07-23
HUT67027A (en) 1995-01-30
IL100693A0 (en) 1992-09-06
TW198024B (show.php) 1993-01-11
ZA92341B (en) 1992-09-30
DE69222444D1 (de) 1997-11-06
IE920149A1 (en) 1992-07-29
PL169417B1 (pl) 1996-07-31
BR9200171A (pt) 1992-10-06
FI107919B (fi) 2001-10-31
NO178397C (no) 1996-03-20
US5100891A (en) 1992-03-31
NO920235D0 (no) 1992-01-17
RO112505B1 (ro) 1997-10-30
NO178397B (no) 1995-12-11
CA2059610A1 (en) 1992-07-19
NO920235L (no) 1992-07-20
JP2665422B2 (ja) 1997-10-22
CS12992A3 (en) 1992-08-12
EP0496314B1 (en) 1997-10-01
ATE158790T1 (de) 1997-10-15
FI102174B (fi) 1998-10-30
HU9200172D0 (en) 1992-04-28
PL167465B1 (pl) 1995-09-30
EP0496314A1 (en) 1992-07-29
PL296651A1 (en) 1993-07-26
GR3025318T3 (en) 1998-02-27
FI920192A0 (fi) 1992-01-16
CA2059610C (en) 2002-04-02
ES2109953T3 (es) 1998-02-01
PL293209A1 (en) 1993-04-05
NZ241305A (en) 1994-10-26

Similar Documents

Publication Publication Date Title
TW198024B (show.php)
NO952018L (no) Substituerte 3-(aminoalkylamino)-1,2-benzisoksazoler og beslektede forbindelser
BR9106518A (pt) Preparacao de piperidinas substituidas
UA26893C2 (uk) Спосіб отримаhhя оhдасетроhу та його фармацевтичhо прийhятhих солей
PL294803A1 (en) Method of obtaining novel ((aryloalkyl-piperidin-4-yl)methyl)-2a,3,4.5-tetrahydro-1(2h)-acenaphtylen-1-ones
DE69533214D1 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
DE69709252D1 (de) Coumarin-Derivate, Verfahren zu deren Herstellung und deren Verwendung
ATE281460T1 (de) Pyrido-1,2,4-thiadiazine und pyrido-1-4- thiazinderivate, ihre herstellung und ihre verwendung
IL132269A0 (en) Process and intermediates for a beta3-adrenergic receptor agonist
ATE247641T1 (de) Pyridin-zwischenprodukte, verwendbar zur herstellung von beta-adrenergischen rezeptor- agonisten
DK0758336T3 (da) Fremgangsmåde til fremstilling af 1-(3-trialkylsilylphenyl)-2,2,2-trifluorethanonderivater
TW429249B (en) Process for production a novel N-substituted pyrrolidine derivatives
FI875602A0 (fi) Optiskt aktivt tetrahydro-2-furanonderivat saosom miksobicid.
MX9703368A (es) Procedimiento para la preparacion de derivados de 1-halogeno-3-trialquilsilanil-benceno.